KRTX
Karuna Therapeutics Inc

2,593
Loading...
Loading...
News
all
press releases
Deutsche Bank AG Buys 7,282 Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Deutsche Bank AG raised its holdings in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX Free Report) by 16.4% during the third quarter, according to its most recent disclosure with the...
Zolmax·1y ago
News Placeholder
More News
News Placeholder
Bristol Myers completes acquisition of Karuna Therapeutics
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
Q1 2024 EPS Estimates for Karuna Therapeutics, Inc. (NASDAQ:KRTX) Reduced by Zacks Research
Karuna Therapeutics, Inc. (NASDAQ:KRTX Free Report) Zacks Research decreased their Q1 2024 earnings estimates for shares of Karuna Therapeutics in a research report issued to...
Zolmax·1y ago
News Placeholder
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Given Consensus Rating of "Hold" by Analysts
Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Free Report) has been given an average recommendation of Hold by the sixteen research firms that are currently covering the stock...
Ticker Report·1y ago
News Placeholder
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Receives Average Recommendation of "Hold" from Brokerages
Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Free Report) have received a consensus recommendation of Hold from the sixteen brokerages that are currently covering the...
Ticker Report·1y ago
News Placeholder
Karuna Therapeutics, Inc. Expected to Earn FY2026 Earnings of ($4.32) Per Share (NASDAQ:KRTX)
Karuna Therapeutics, Inc. (NASDAQ:KRTX Free Report) Stock analysts at Zacks Research issued their FY2026 earnings estimates for shares of Karuna Therapeutics in a research report...
Ticker Report·1y ago
News Placeholder
When Will Karuna Therapeutics, Inc. (NASDAQ:KRTX) Turn A Profit?
With the business potentially at an important milestone, we thought we'd take a closer look at Karuna Therapeutics...
Simply Wall St·1y ago
News Placeholder
Karuna Therapeutics (KRTX, $329.71) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 14, 2024
This is a Bullish indicator signaling KRTX's price could rise from here. Traders may explore going long the stock or buying call options...
Tickeron - Stocks·1y ago
News Placeholder
Karuna Therapeutics (KRTX, $329.71) RSI Indicator left the overbought zone on March 14, 2024
This is a signal that KRTX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Tickeron - Stocks·1y ago
News Placeholder
Karuna Therapeutics gains as HSR waiting period for Bristol-Myers deal expires
Karuna Therapeutics gains as HSR waiting period for Bristol-Myers deal expires...
SeekingAlpha.com: All News·1y ago

Latest KRTX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.